Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
3.900
+0.440 (12.72%)
At close: Nov 7, 2025, 4:00 PM EST
3.830
-0.070 (-1.79%)
After-hours: Nov 7, 2025, 5:55 PM EST
Entero Therapeutics Employees
The last reported number of employees for Entero Therapeutics was 2.
Employees
2
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
6.19M
No historical employees data available.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ENTO News
- 1 day ago - Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid - Accesswire
- 8 days ago - Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO) - Accesswire
- 8 days ago - Entero Regains Nasdaq Compliance With Grid AI Acquisition - Accesswire
- 22 days ago - Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid - Accesswire
- 24 days ago - From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO) - Accesswire
- 24 days ago - Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It - Accesswire
- 5 weeks ago - Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus - Benzinga
- 5 weeks ago - ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI - Accesswire